UBS’s DURECT Corp DRRX Stock Holding History

UBS’s Portfolio DRRX Stock Details DRRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$11K	Buy	737 +702	+2,006%	+$10.9K	﹤0.01%	8702
2014 Q2	$1K	Sell	35 -4,088	-99%	-$57.4K	﹤0.01%	10197
2014 Q1	$54K	Buy	4,123 +4,088	+11,680%	+$71.2K	﹤0.01%	6728
2013 Q4	$1K	Sell	35 -617	-95%	-$9.33K	﹤0.01%	10181
2013 Q3	$8K	Buy	652 +617	+1,763%	+$7.32K	﹤0.01%	9007
2013 Q2	$0	Buy	+35	New	+$390	﹤0.01%	10176

Other funds holding DRRX

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

IIM

Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

UBS's DRRX Position: Q3 2014 in Review

UBS increased its DURECT Corp (DRRX) stake by 2,006% in Q3 2014, buying an estimated $10.9K and bringing the position to 737 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #8702.

UBS first reported a position in DRRX in Q2 2013 and has held it in 6 quarters since. The position peaked at $54K in Q1 2014. 63 funds tracked by Wall St. Rank hold DRRX as of Q3 2014.

UBS held 737 shares of DURECT Corp worth $11K as of Q3 2014.
UBS bought 702 DURECT Corp shares in Q3 2014, an estimated $10.9K.
DURECT Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8702 holding.
UBS first reported a position in DURECT Corp in Q2 2013 and has held it in 6 quarters since.
UBS's DURECT Corp position peaked at $54K in Q1 2014.
63 funds tracked by Wall St. Rank held DURECT Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.